Skip to main content
Clinical Trials/JPRN-UMIN000043518
JPRN-UMIN000043518Completed未知

Comparison of reversal with neostigmine vs. sugammadex for postoperative bowel function in patients undergoing colorectal surgery - comparison of reversal with neostsigmine and sugammadex for post.op bowel function in patients undergoing colorectal surg.

self0 sites122 target enrollmentStarted: September 14, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
self
Enrollment
122

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Patients who have been given drugs that affect muscle relaxation recovery (anticonvulsants, antidepressants, etc.) 2. Patients who had history of neuromuscular diseases 3. Patients with hypersensitivity to rocuronium, neostigmine, and sugammadex 4. Patients with liver disease (OT/PT> 40 IU/L), kidney disease (Cr> 1.4 mg/dl) 5. Patients with with bowel obstruction 6. Patients who disagree with the test

Investigators

Sponsor
self

Similar Trials

Comparison of reversal with neostigmine... | Clinical Trial